SUCCESSFUL TREATMENT OF LUPUS NEPHRITIS IN MRL-LPR LPR MICE BY INHIBITING ORNITHINE DECARBOXYLASE

被引:20
|
作者
GUNNIA, UB
AMENTA, PS
SEIBOLD, JR
THOMAS, TJ
机构
[1] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, CLIN RES CTR, NEW BRUNSWICK, NJ 08903 USA
[2] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT MED, DIV RHEUMATOL, NEW BRUNSWICK, NJ 08903 USA
[3] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT PATHOL, NEW BRUNSWICK, NJ 08903 USA
关键词
D O I
10.1038/ki.1991.111
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Ornithine decarboxylase (ODC) is a key enzyme in the biosynthesis of cellular polyamines, putrescine, spermidine and spermine. Difluoromethylornithine (DFMO) is an irreversible inhibitor of ODC and thereby depletes putrescine and spermidine levels in vivo and in vitro. Previous studies in lupus-prone MRL-lpr/lpr mice treated with 1% DFMO in drinking water have been associated with improved lifespan, and reduced anti-DNA antibody production, lymphadenopathy, and splenic polyamine levels. Since glomerulonephritis is a major cause of morbidity and mortality in lupus, we studied the effect of DFMO on renal histology of MRL-lpr/lpr mice. Female BALB/c and MRL-+/+ mice were used as controls. Dose response studies revealed that 1.5% DFMO in drinking water had maximum therapeutic efficacy and produced a significant 79% increase in the median lifespan of a group of 20 mice compared to an equal number of controls (P < 0.001). Renal histologic studies were performed on kidney sections from four to five mice each from DFMO-treated and untreated groups at 12, 16, 20, 24 and 29 weeks of age. Sections were read blinded to duration and treatment and scored by four major histologic criteria (glomerulonephritis, interstitial inflammation, perivascular inflammation, and vasculitis) and showed significant reduction in all these parameters in DFMO-treated mice when compared to age- and sex-matched untreated mice of the same strain. DFMO treatment had no significant effect on pulmonary histologic findings on these mice. DFMO treatment reduced ODC activity and polyamine concentrations in treated mice. Basal ODC activity of 24-week-old untreated and DFMO-treated MRL-lpr/lpr mice was 142 +/- 14 and 27 +/- 6 pmol CO2/mg protein/hr, respectively. Basal kidney ODC activity of normal BALB/c and MRL-+/+ mice was 78 +/- 14 and 93 +/- 21 pmol CO2/mg protein/hr, respectively and indicated a constitutively high level of ODC activity in lupus-prone MRL-lpr/lpr mice compared to other strains. These data suggest an important role of endogenous polyamines in the tissue injury of lupus and suggest novel approaches to therapy of lupus-related renal disease.
引用
收藏
页码:882 / 890
页数:9
相关论文
共 50 条
  • [1] THE ROLE OF POSTTRANSCRIPTIONAL MODIFICATIONS OF ORNITHINE DECARBOXYLASE (ODC) IN THE PATHOGENESIS OF LUPUS NEPHRITIS IN MRL-LPR LPR MICE
    HSU, HC
    THOMAS, T
    SEIBOLD, JR
    THOMAS, TJ
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S155 - S155
  • [2] Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice
    Bloom, RD
    O'Connor, T
    Cizman, B
    Kalluri, R
    Naji, A
    Madaio, MP
    INTERNATIONAL IMMUNOLOGY, 2002, 14 (08) : 867 - 871
  • [3] CIRCULATING EXOSOMES PROMOTE LUPUS NEPHRITIS IN MRL-LPR MICE
    Sha, X.
    Ge, X.
    Jin, Y.
    Chen, T.
    Ni, X.
    Zheng, W.
    Ji, J.
    Gu, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 646 - 647
  • [4] Inhibitory oligodeoxynucleotide inhibits the progression of autoimmune nephritis in the lupus prone MRL-lpr/lpr mice.
    Hoshi, N
    Watanabe, H
    Kobayashi, H
    Sato, Y
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S627 - S628
  • [5] STUDIES OF LYMPHOPROLIFERATION IN MRL-LPR/LPR MICE
    SMATHERS, PA
    SANTORO, TJ
    CHUSED, TM
    REEVES, JP
    STEINBERG, AD
    JOURNAL OF IMMUNOLOGY, 1984, 133 (04): : 1955 - 1961
  • [6] DIFFERENTIAL-EFFECTS OF AN ORNITHINE DECARBOXYLASE INHIBITOR ON T-HELPER AND SUPPRESSOR CELLS IN MRL-LPR/LPR MICE
    THOMAS, TJ
    CLINICAL RESEARCH, 1990, 38 (02): : A580 - A580
  • [7] TWEAKing Cutaneous Manifestations In MRL-Lpr/Lpr Lupus Prone mice.
    Xia, Yumin
    Blecher, Karin
    Wen, Jing
    Michaelson, Jennifer S.
    Burkly, Linda C.
    Friedman, Adam
    Putterman, Chaim
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S713 - S713
  • [8] Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice
    Zeming Zhang
    Dongmei Liu
    Xiaoli Zhang
    Xiaofei Wang
    Inflammation, 2018, 41 : 1888 - 1899
  • [9] Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice
    Zhang, Zeming
    Liu, Dongmei
    Zhang, Xiaoli
    Wang, Xiaofei
    INFLAMMATION, 2018, 41 (05) : 1888 - 1899
  • [10] Immunotoxicity of trichloroethylene:: a study with MRL-lpr/lpr mice
    Kaneko, T
    Saegusa, M
    Tasaka, K
    Sato, A
    JOURNAL OF APPLIED TOXICOLOGY, 2000, 20 (06) : 471 - 475